A Randomized, Double-Blind, Phase I/II Study of CT-P13 Compared with Remicade in Patients with Rheumatoid Arthritis
Latest Information Update: 11 Feb 2022
At a glance
- Drugs Infliximab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Nippon Kayaku
- 01 Jun 2016 New trial record